Themis Medicare Limited

Web: themismedicare.com NSE: THEMISMED BSE: 530199 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

122 3(-2%)

Volume

58L as on 23, Jun

Open

263

High

265

Low

262

125

VWAP

125

52 Week High

148

52 Week Low

Viand Research Rating

Quality Score

32/100

Growth Score

50/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

1,123

No. of Shares

9.21

P/E

77.91

P/B

8.07

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

10.36

ROCE

Profit Growth

Listing Date

02-Apr-07

Promoter Holding

67.1%

FII Holding

0.01%

DII Holding

0.01%

Price Chart

Price Performance

1 Week19%

1 Month21%

3 Months70%

6 Months48%

1 Year48%

YTD48%

Moving Average

5 Day SMA109

10 Day SMA106

20 Day SMA106

30 Day SMA104

50 Day SMA100

61 Day SMA95

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	147	123	135	151
Resistance 2	135	121	127	137
Resistance 1	126	119	122	130
Pivot Point	113	117	113	115
Support 1	105	115	105	109
Support 2	92	113	100	94
Support 3	84	112	92	88

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 67.10%	(0.01) 67.10%	(-0.11) 67.10%	(0.01) 67.15%	(0.01) 67.15%	(0.01) 67.15%	(0.01) 67.15%	(0.01) 67.15%	(0.01) 67.15%	(0.01) 67.15%	(0.01) 67.16%	(0.01) 67.16%	(0.01) 67.16%	(0.01) 67.16%	(0.01) 67.17%	(0.01) 67.17%	(0.01) 67.18%	(0.01) 67.18%	(0.01) 67.18%	(0.01) 67.18%
FIIs	(-0.11) 0.01%	(0.11) 0.11%	(0.01) 0.05%	(0.01) 0.06%	(-0.11) 0.09%	(0.01) 0.14%	(0.01) 0.10%	(0.11) 0.10%	(0.01) 0.05%	(0.01) 0.03%	(0.01) 0.01%	(0.01) 0.05%	(0.01) 0.04%	(0.01) 0.06%	(0.01) 0.02%	(0.01) 0.02%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%
DIIs	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.01%
Public	32.87%	32.78%	32.84%	32.77%	32.75%	32.70%	32.75%	32.74%	32.79%	32.81%	32.82%	32.77%	32.80%	32.78%	32.78%	32.80%	32.81%	32.81%	32.81%	32.81%
No. of Shareholders	21,267	21,818	22,576	22,490	19,335	17,889	17,773	14,270	11,322	11,295	11,244	6,970	6,007	5,927	6,362	6,126	5,915	5,891	6,212	6,511

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	87	77	90	78	98	72	94	117	123	98	83	105	97	80.1	89	91	94	79.8	94.92	107	112
Sales Growth % (YoY)	-10.9%	6.7%	-3.9%	-33.4%	-20.7%	-26.7%	13.7%	11.7%	27.2%	22.1%	-7.1%	15.1%	2.3%	0.4%	-6.5%	-15.3%	-16%	29.2%	44.9%	95.6%	132%
Sales Growth % (QoQ)	13%	-14.4%	15.4%	-20.4%	36.1%	-23.4%	-19.7%	-4.9%	25.5%	18.1%	-21%	8.2%	21.1%	-10%	-2.2%	-3.2%	17.8%	-15.9%	-11.3%	-4.5%	-
Expenses	139	73	80	81	108	79	88	100	94	89	74	92	75	69.62	74	69.66	74	65.39	77.62	84	72
Operating Profit	-52	4	10	-3	-10	-8	6	17	29	9	8	12	22	10.48	15	21.34	20	14.41	17.3	23	40
OPM %	-60	4.9	11	-4	-10	-11	6	15	24	10	10	12	22	13.08	17	23.45	22	18.06	18.23	22	36
Other Income	97	11	6	5	1	2	1	6	7	5	6	7	6	5.32	7	6.22	6	4.25	4.44	4	5
Interest	3	3	3	3	2	2	3	2	2	2	3	2	2	2.71	2	2.37	2	1.93	2.13	2	3
Depreciation	3	3	3	3	3	3	3	2	2	3	3	3	3	2.8	3	2.56	2	2.39	2.37	2	2
Profit before tax	39	9	10	-3	-14	-11	2	18	31	9	8	14	23	10.29	18	22.63	22	14.34	17.24	23	40
Tax %	36	2	3	5	1	-13	69	20	21	24	10	19	19	18.37	24	21.43	21	30.61	27.78	18	23
Net Profit	25	9	10	-4	-14	-10	1	14	25	7	7	11	18	8.41	13	17.78	17	9.95	12.46	19	31
Net Profit Growth % (QoQ)	177.8%	-10%	350%	71.4%	-40%	-1100%	-92.9%	-44%	257.1%	-	-36.4%	-38.9%	114%	-35.3%	-26.9%	4.6%	70.9%	-20.1%	-34.4%	-38.7%	-
Net Profit Growth % (YoY)	278.6%	190%	900%	-128.6%	-156%	-242.9%	-85.7%	27.3%	38.9%	-16.8%	-46.2%	-38.1%	5.9%	-15.5%	4.3%	-6.4%	-45.2%	-	-	-	-
TTM Net Profit	40	1	-18	-27	-9	30	47	53	50	43	44.41	50.41	57.19	56.19	57.73	57.19	58.41	72.41	62.46	50	0
EPS in Rs	2.67	0.97	1.1	-0.39	-1.54	-1.05	0.06	1.55	2.68	0.72	0.8	1.23	1.98	0.91	1.45	1.93	1.89	1.08	1.35	2.1	3.39

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	342	406	382	354	395	231	202	184	210	217	232	202	195	174
Sales Growth %	-15.6%	6.2%	7.7%	-10.2%	71.1%	14.4%	9.7%	-12.3%	-3.3%	-6.8%	15.1%	3.5%	12.4%	10%
Expenses	342	356	330	287	299	181	166	181	184	184	194	184	171	157
Operating Profit	0	49	52	67	96	49	36	2	25	33	38	18	24	17
OPM %	0.1	12	13	19	24	21	18	1.2	12	15	16	9	12	10
Other Income	23	11	24	25	18	13	12	5	6	4	3	13	5	3
Interest	11	10	9	10	9	13	13	12	12	12	12	15	16	15
Depreciation	10	10	12	10	9	9	8	8	7	7	12	11	9	9
Profit before tax	2	40	53	73	95	41	27	-13	11	18	17	5	4	-4
Tax %	40	25	19	22	23	14	8	-15	1	9	11	-20	32	56
Net Profit	1	30	44	57	73	36	25	-11	11	16	16	6	3	-6
Net Profit Growth %	-96.7%	-31.8%	-22.8%	-21.9%	102.8%	44%	327.3%	-200%	-31.2%	-	166.7%	100%	150%	-
EPS in Rs	0.12	3.24	4.73	6.18	7.92	3.88	2.7	-1.17	1.23	1.77	1.91	0.73	0.32	-0.79
Dividend Payout %	404	15	11	8	6	11	6	0	0	0	9	25	28	-11

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	-3	35	22	16	34	57	0	11	8	-2	26	19	8	4
Cash from Investing Activity	-3	-12	-16	-24	-16	-16	-5	-4	0	-4	-7	-6	-7	-5
Cash from Financing Activity	4	-26	-9	0	-18	-26	7	-10	-9	5	-13	-18	2	29
Net Cash Flow	-2	-3	-3	-8	1	16	2	-3	-1	0	5	-5	4	29

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	9	9	9	9	9	9	9	9	9	9	9	9	9	8	8	8
Reserves	389	371	393	403	368	330	278	209	174	149	160	143	66	51	48	44
Borrowings	100	96	83	81	96	92	80	87	100	82	80	82	128	140	148	155
Other Liabilities	99	107	102	109	93	82	61	65	67	74	56	54	73	77	79	65
Total Liabilities	598	582	588	602	566	514	428	371	350	314	305	289	275	277	284	272
Fixed Assets	167	169	172	174	168	162	144	133	116	123	126	124	117	122	121	124
CWIP	2	3	3	3	3	3	3	2	8	2	2	9	6	4	12	11
Investments	109	96	95	99	89	70	56	45	35	27	24	23	6	5	4	4
Other Assets	320	314	318	326	307	279	225	191	191	162	153	133	146	146	147	134
Total Assets	598	582	588	602	566	514	428	371	350	314	305	289	275	277	284	272

Delivery

Delivery Data: THEMISMED

#	Date	101 32% 134	Value (Cr)	Q/T 62	Del 43	Del 3
1	4-Sep	120	2	57	48	1
2	3-Sep	125	1	51	38	0
3	2-Sep	124	1	54	58	1
4	1-Sep	124	2	57	45	1
5	31-Aug	125	2	57	46	1
6	28-Aug	125	1	89	68	1
7	27-Aug	126	2	55	41	1
8	26-Aug	126	21	68	26	6
9	25-Aug	119	6	71	25	2
10	24-Aug	121	13	84	36	5
11	21-Aug	106	1	54	50	1
12	20-Aug	103	1	78	62	0
13	19-Aug	104	1	72	66	0
14	18-Aug	107	1	67	63	1
15	17-Aug	104	1	57	60	0
16	14-Aug	105	1	85	57	1
17	13-Aug	104	7	102	19	1
18	12-Aug	109	1	63	52	0
19	11-Aug	113	1	87	48	1
20	10-Aug	109	1	64	51	1
21	7-Aug	110	0	56	73	0
22	6-Aug	113	0	45	63	0
23	5-Aug	116	1	54	59	1
24	4-Aug	115	3	74	50	1
25	3-Aug	107	0	34	52	0
26	31-Jul	105	0	37	59	0
27	30-Jul	104	0	51	69	0
28	29-Jul	107	0	27	42	0
29	28-Jul	106	0	28	56	0
30	27-Jul	108	0	24	41	0
31	24-Jul	110	0	39	45	0
32	23-Jul	108	0	37	42	0
33	22-Jul	108	1	43	50	0
34	21-Jul	112	0	28	40	0
35	20-Jul	113	3	49	15	0
36	17-Jul	110	1	36	50	0
37	16-Jul	112	1	54	68	1
38	15-Jul	116	1	21	40	0
39	14-Jul	117	2	34	22	0
40	13-Jul	116	0	39	50	0
41	10-Jul	117	1	51	41	0
42	9-Jul	116	1	40	46	0
43	8-Jul	112	1	42	60	0
44	7-Jul	117	1	51	46	1
45	6-Jul	121	2	74	57	1
46	3-Jul	119	3	62	42	1
47	2-Jul	119	23	93	13	3
48	1-Jul	111	1	62	43	1
49	30-Jun	110	3	81	48	1
50	29-Jun	113	1	70	38	1

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	1,123c	27c	2.35
03-Sep	1,150c	27c	2.28
01-Sep	1,176c	36c	3.17
31-Aug	1,140c	11c	0.95
27-Aug	1,151c	48c	3.97
26-Aug	1,199c	101c	9.23
25-Aug	1,097c	12c	1.12
24-Aug	1,110c	150c	15.58
21-Aug	960c	6c	0.61
19-Aug	966c	10c	1.04
18-Aug	976c	9c	0.93
17-Aug	985c	23c	2.37
14-Aug	963c	75c	7.27
13-Aug	1,038c	50c	5.03
12-Aug	988c	26c	2.60
11-Aug	1,015c	1c	0.13
10-Aug	1,016c	2c	0.16
07-Aug	1,014c	40c	3.77
06-Aug	1,054c	92L	0.09
05-Aug	1,055c	45c	4.40
04-Aug	1,010c	44c	4.60
31-Jul	966c	2c	0.20
30-Jul	968c	29c	2.93
29-Jul	997c	21c	2.14
28-Jul	976c	18c	1.83
27-Jul	995c	25c	2.40
24-Jul	1,019c	0	0

Stock Checklist

Price is above from 52 week high low average: 69%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 2 fund scheme(s) across 1 fund house(s) as of Aug26 · Total value ₹0 Cr · 0 increasing / 0 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
Bandhan Mutual Fund	2	0.00%	-	0

Themis Medicare Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements